Submission to first decision (The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor)
Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date.
3 weeks
Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) 6 weeks
Submission to final decision (The average time from manuscript submission to the final editorial decision) 16 weeks
Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) 24 weeks

ACTA Pharmaceutica Sciencia 2017 , Vol 55 , Num 3
The Effects of Some Imidazopyrazine Derivatives on Telomerase Inhibition, mtDNA Damage and mtDNA Copy Number
Ayşe Gül Mutlu 1 Abdulkerim Bilginer 2 Ismail Kayağil 3 Hülya Yıldız 2 Ülkü Bayhan 4 İnanç Yılmaz 4 Şeref Demirayak 5
1 Mehmet Akif Ersoy University, Arts and Sciences Faculty, Department of Molecular Biology and Genetics, Burdur, Turkey
2 Mehmet Akif Ersoy University, Arts and Sciences Faculty, Department of Biology, Burdur, Turkey
3 Mehmet Akif Ersoy University, Arts and Sciences Faculty, Department of Chemistry, Burdur, Turkey
4 Mehmet Akif Ersoy University, Arts and Sciences Faculty, Department of Physics, Burdur, Turkey
5 Medipol University, Faculty of Pharmacy, İstanbul, Turkey
DOI : 10.23893/1307-2080.APS.05517 Viewed : 18740 - Downloaded : 6249 Imidazopyrazine derivatives have been studied for their curative effects on some diseases like cancer and neurological problems; also, some of these molecules have been patented. Primary human cells exhibit limited replicative potential but the cancer cells divided unlimitedly with passage in culture. This immortality is mainly a result of telomerase activity. We investigated the possible telomerase inhibitor effect and possible mtDNA damage action of five imidazopyrazine derivatives. Telomerase activities were measured by the PCR-ELISA based TRAP method and mtDNA damage assays were achieved by quantitative PCR. We used zebrafish as a model organism for our research. In the application of 6-(4-Metylphenyl-8-(4- chlorophenyl)imidazo[1,2-a]pyrazine (C19H14N3Cl), it was determined that this compound inhibit telomerase activities to a statistically significant degree. The obtained results from molecular docking studies also supported the experimental results. Accordingly, this compound has the probability to be used as an anti-cancer agent after detailed studies. Keywords : Imidazopyrazine derivatives, Telomerase inhibition, mtDNA damage, mtDNA copy number, anticancer drugs

Istanbul Medipol University